What Is CAR T-cell Therapy?
With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
Tag: cancer patients
With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
The summer issue of Cancer Today includes articles about integrating patient-reported outcomes into clinical research and care, advances in...
Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR...
After surviving brain cancer, former competitive cyclist Chris Baccash dedicated his life to helping others. Baccash now uses his...
Researchers are building AI agents to assess how patients could respond to therapy and aid doctors in making cancer...
At the AACR Annual Meeting 2026, researchers discussed the use of vaccines and aspirin to prevent cancer in people...
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
Patient advocates from the AACR Scientist↔Survivor Program shared their research on cancer during the AACR Annual Meeting 2026.
Injecting immunotherapy directly into precancerous oral lesions may be an effective way to prevent progression to cancer without surgery.
The spring 2026 issue of Cancer Today included articles about using AI chatbots, cancer survivor—and “Survivor” winner—Ethan Zohn, and...